In early ARDS, we detected an increase in the proportion of CD14+CD16+ intermediate monocytes at the expense of classical CD14++CD16− monocytes (Extended Data Fig. 1a–c)12. This evidence concerns the gene CD14 and acute respiratory distress syndrome.